Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02404441
Title Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Recruitment Completed
Gender
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

stomach cancer

Advanced Solid Tumor

anal canal cancer

renal cell carcinoma

esophagus adenocarcinoma

melanoma

lung non-small cell carcinoma

Therapies

Spartalizumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN


No variant requirements are available.